Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 5
Submit an article Journal homepage
293
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of Epstein–Barr Virus in Patients with Intraocular Inflammation

Kareem Moussaa Department of Ophthalmology and Vision Science, University of California, Davis, Sacramento, California, USA;b F.I. Proctor Foundation, San Francisco, California, USA;c Department of Ophthalmology, University of California, San Francisco, California, USACorrespondence[email protected]
View further author information
, MD,
John A. Gonzalesb F.I. Proctor Foundation, San Francisco, California, USA;c Department of Ophthalmology, University of California, San Francisco, California, USAORCID Iconhttps://orcid.org/0000-0003-0558-9793View further author information
, MDORCID Icon,
Jessica Shanthab F.I. Proctor Foundation, San Francisco, California, USA;c Department of Ophthalmology, University of California, San Francisco, California, USAView further author information
, MD,
Nisha R. Acharyab F.I. Proctor Foundation, San Francisco, California, USA;c Department of Ophthalmology, University of California, San Francisco, California, USAView further author information
, MD, MS &
Thuy Doanb F.I. Proctor Foundation, San Francisco, California, USA;c Department of Ophthalmology, University of California, San Francisco, California, USAORCID Iconhttps://orcid.org/0000-0003-2733-8370View further author information
, MD, PhDORCID Icon
Pages 978-980 | Received 05 Jan 2022, Accepted 05 May 2022, Published online: 16 Jun 2022

References

  • Takahashi H, Takase H, Arai A, Mochizuki M, Ohno-Matsui K. Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection. BMC Ophthalmol. 2019;19(1):83. doi:10.1186/s12886-019-1090-5.
  • Ban Y, Okamoto M, Ogata N. Case of primary intraocular lymphoproliferative disorder caused by Epstein-Barr virus. BMC Ophthalmol. 2020;20(1):306. doi:10.1186/s12886-020-01583-x.
  • Rohrbach JM, Kröber SM, Teufel T, Kortmann RD, Zierhut M. EBV-induced polymorphic lymphoproliferative disorder of the iris after heart transplantation. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2004;242(1):44–50. doi:10.1007/s00417-003-0751-4.
  • Sato T, Kitamura R, Kaburaki T, Takeuchi M. Retinitis associated with double infection of Epstein-Barr virus and varicella-zoster virus: a case report. Medicine (Baltimore). 2018;97(31):e11663. doi:10.1097/MD.0000000000011663.
  • Usui M, Sakai J. Three cases of EB virus-associated uveitis. Int Ophthalmol. 1990;14(5–6):371–376. doi:10.1007/BF00163559.
  • Ongkosuwito JV, Van der Lelij A, Bruinenberg M, et al. Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. Br J Ophthalmol. 1998;82(3):245–251. doi:10.1136/bjo.82.3.245.
  • Smit D, Meyer D, Maritz J, de Groot-Mijnes JDF. Polymerase chain reaction and Goldmann-Witmer coefficient to examine the role of Epstein-Barr virus in uveitis. Ocul Immunol Inflamm. 2019;27(1):108–113. doi:10.1080/09273948.2017.1370653.
  • Yamamoto S, Sugita S, Sugamoto Y, Shimizu N, Morio T, Mochizuki M. Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J Ophthalmol. 2008;52(6):463–467. doi:10.1007/s10384-008-0589-8.
  • Groen-Hakan F, Van Der Eijk AA, Rothova A. The usefulness of aqueous fluid analysis for Epstein-Barr virus in patients with uveitis. Ocul Immunol Inflamm. 2020;28(1):126–132. doi:10.1080/09273948.2018.1543709.
  • Doan T, Wilson MR, Crawford ED, et al. Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens. Genome Med. 2016;8(1):90. doi:10.1186/s13073-016-0344-6.
  • Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350(13):1328–1337. doi:10.1056/NEJMra032015.
  • Gasser O, Bihl FK, Wolbers M, et al. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS Med. 2007;4(3):e96. doi:10.1371/journal.pmed.0040096.
  • Jaffe ES, Pittaluga S. Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematol Am Soc Hematol Educ Program. 2011;2011:506–514. doi:10.1182/asheducation-2011.1.506.
  • Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 2007;110(3):972–978. doi:10.1182/blood-2007-01-067769.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.